You are here

  • Home
  • Archive
  • Volume 2018, Issue
  • Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C

Article metrics

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C

 

Online download statistics by month:

Online download statistics by month: June 2018 to March 2024

AbstractFullPdf
Jun 2018276107
Jul 201860110
Aug 20182101
Sep 20181811
Oct 20181213
Nov 20183525
Dec 20181900
Jan 20197110
Feb 20198000
Mar 20198600
Apr 20195111
May 20191500
Jun 20192001
Jul 20191710
Aug 20192511
Sep 20194311
Oct 20194400
Nov 20191200
Dec 20193910
Jan 20202131
Feb 20203110
Mar 20201220
Apr 20201631
May 20203110
Jun 20203551
Jul 202012510
Aug 20203821
Sep 20206700
Oct 20206610
Nov 20205613
Dec 20205000
Jan 20211400
Feb 20211800
Mar 20211000
Apr 20212001
May 2021300
Jul 2021212
Sep 2021001
Oct 20213511
Nov 20211000
Dec 20212200
Jan 20222150
Feb 2022400
Mar 20221511
Apr 20222422
May 20221910
Jun 20221400
Jul 20222400
Aug 20221500
Sep 2022931
Oct 20221000
Nov 20222611
Dec 2022600
Jan 20235530
Feb 2023600
Mar 2023800
Apr 2023500
May 2023800
Jun 2023600
Jul 20231200
Aug 2023400
Sep 2023310
Oct 2023200
Nov 20231220
Dec 20231300
Jan 20241500
Mar 2024600
Total19686248